- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02884921
Preemptive Analgesia Using Intravenous Paracetamol
Preemptive Analgesia Using Intravenous Paracetamol in Dental Sitting
Dental treatment for children should be done in a calm atmosphere and without pain. Oral Propacetamol has been shown to be effective in a variety of postsurgical pain models.
There are no studies on paracetamol preemptive analgesia effect on the pediatric population in the dental setting which compare analgesic effect when administered before Vs after the dental treatment.
The investigators hypothesis is that preoperative intravenous paracetamol are helpful in the prevention of postoperative pain in children undergoing dental treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dental treatment for children should be done in a calm atmosphere and without pain in purpose to achieve a positive feelings and response towards dental treatment.Postoperative pain is the main issue which may cause a negative attitude of the child to dental treatment in future appointment. One of the affective options to deal with this pain is to give analgesic drug before the initiative of treatment which should continue its effect during and may also after treatment which is known as "preemptive analgesia. Oral Propacetamol has been shown to be effective in a variety of postsurgical pain models. In double blind clinical trials single or multiple dose of intravenous paracetamol, generally provided significantly better analgesic effect than placebo treatment in adults' patients who had undergone dental, orthopedic or gynecological surgery. There is considerable evidence that the analgesic effect of paracetamol is central and is due to activation of descending serotonergic pathways, but its primary site of action may still be inhibition of prostaglandin synthesis by its selective inhibition of Cox-2 isoenzyme.
At the best of the investigators knowledge, there are no studies on paracetamol preemptive analgesia effect on the pediatric population in the dental setting which compare analgesic effect when administered before Vs after the dental treatment.
The investigators hypothesis is that preoperative intravenous paracetamol are helpful in the prevention or modification of postoperative pain in children undergoing dental treatment.
The primary outcome of this study is to investigate the post dental treatment analgesic effect of intravenous paracetamol in children when administered before compared to after dental treatment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- All children who require a wide treatment of caries
- Children of high score of anxious or who is stressfully
Exclusion criteria:
- Contraindication for paracetamol
- Renal or hepatic insufficiency
- Patient have history of allergy for paracetamol
- Anemia of Hgb less than 10 gr/DL
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
|
Placebo
|
|
Active Comparator: Preemptive Paracetamol
|
Paracetamol
|
|
Active Comparator: Post surgery Paracetamol
|
Paracetamol
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain measure in numerical scale
Time Frame: 1-24 hours
|
Post operative Pain measure in numerical scale from 1 to 10
|
1-24 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: mira koch, Ethicla Committee Bnai Zion Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BnaiZionMC-16-LG-008
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adverse Anesthesia Outcome
-
Bnai Zion Medical CenterUnknownAdverse Anesthesia Outcome
-
Bnai Zion Medical CenterUnknownAdverse Anesthesia Outcome
-
Bnai Zion Medical CenterCompletedAdverse Anesthesia OutcomeIsrael
-
Bnai Zion Medical CenterUnknownAdverse Anesthesia Outcome
-
Bnai Zion Medical CenterHospital Italiano de Buenos AiresCompletedAdverse Anesthesia Outcome
-
Schulthess KlinikCompletedAdverse Anesthesia OutcomeSwitzerland
-
Schulthess KlinikUniversity of SalzburgCompletedAdverse Anesthesia Outcome
-
Schulthess KlinikMedical University InnsbruckCompletedAdverse Anesthesia OutcomeAustria
-
Bnai Zion Medical CenterUnknownAdverse Anesthesia Outcome
-
Bnai Zion Medical CenterUnknownAdverse Anesthesia Outcome
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States